Agenus reported $192.3M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Amgen AMGN:US $ 64993M 5220M
AstraZeneca AZN:LN 107221M 33580M
Bristol Myers Squibb BMY:US $ 110893M 96M
Celldex Therapeutics CLDX:US $ 460.2M 255.65M
Chemocentryx CCXI:US $ 454.84M 12.83M
CSL CSL:AU $ 18.16B 465.5M
Dicerna Pharmaceuticals DRNA:US $ 772.06M 66.43M
Dynavax Technologies DVAX:US $ 919.71M 271.8M
Eli Lilly And LLY:US $ 48187M 378M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Genocea Biosciences GNCA:US $ 64.92M 12.46M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Glaxosmithkline GSK:US $ 78689M 1678M
Immunogen IMGN:US $ 296.8M 4.64M
Intrexon XON:US $ 376.9M 25.67M
Jiangsu Hengrui Me. 600276:CH CH 38.95B 1.95B
Karyopharm Therapeutics KPTI:US $ 254.09M 32.47M
Macrogenics MGNX:US $ 392.16M 33.75M
Merck MRK:GR € 43836M 691M
Northwest Biotherapeutics NWBO:US 28.22M 546K
Novartis NOVN:VX SF 121209M 2806M
Novavax NVAX:US $ 2565.94M 183.65M
Regeneron Pharmaceuticals REGN:US $ 23671.5M 2185.6M
Rigel Pharmaceuticals RIGL:US $ 186.52M 15.08M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Veracyte VCYT:US $ 1186.36M 158.92M
YTE INCY:US $ 4198.83M 294.21M